Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, C. Allison Stewart et al.|Cancer Cell|2021Cited by 930
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous CarcinomasJoshua D. Campbell, Esther Drill, Christina Yau et al.|Cell Reports|2018Cited by 366
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Lorenza Landi et al.|Cancer Discovery|2023Cited by 181
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell linesNene N. Kalu, Faye M. Johnson, Tuhina Mazumdar et al.|Oncotarget|2017Cited by 70
The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cellsPriyam Banerjee, Jonathan M. Kurie, Guan-Yu Xiao et al.|Nature Communications|2021Cited by 64